Post Approval Study of the Eversense® Continuous Glucose Monitoring

Clinical trial NCT03908125 · COMPLETED

Trial details

NCT number: NCT03908125
Sponsor: Senseonics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2019-03-19
Primary completion: 2024-02-01
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.